Data as of Aug 29
| +0.14 / +1.38%|
The 6 analysts offering 12-month price forecasts for Horizon Pharma Inc have a median target of 20.00, with a high estimate of 31.00 and a low estimate of 10.00. The median estimate represents a +94.17% increase from the last price of 10.30.
The current consensus among 6 polled investment analysts is to Buy stock in Horizon Pharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.